Biondi, Andrea
Rocchi, L.
Santoro, V.
Rossini, P. G.
Beatch, G. N.
Richardson, M. P.
Premoli, I.
Funding for this research was provided by:
Xenon Pharmaceuticals Inc.
MRC Programme (Grant MR/K013998/1)
EPSRC Centre for Predictive Modelling in Healthcare (EP/N014391/1)
NIHR Biomedical Research Centre and South London and Maudsley NHS Foundation Trust
Article History
Received: 4 December 2020
Accepted: 5 January 2022
First Online: 4 February 2022
Competing interests
: The author GNB declares a conflict of interest, as an employee of Xenon Pharmaceuticals. Inc. Burnaby Canada (ExternalRef removed) and having been granted incentive stock options in the company. The other authors have not conflict of interest to disclose. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.